First Quarter 2018 Highlights
Strong start to operating cash flow, at $216 million in the quarter
Continued revenue growth in managed document services and Global Imaging Systems operations
Adjusted operating margin of 10.4 percent, down 0.6 points year-over-year; operating margin, excluding equity income, up 0.5 points
Core operating profit, excluding equity income, grew 5 percent year-over-year
more detail at: https://www.news.xerox.com/internal_redirect/cms.ipressroom.com.s3.amazonaws.com/84/files/20184/New-Release-May-2-2018-Xerox-Reports-First-Quarter-2018-Results.pdf
Related Posts
The Association of American Publishers released its StatShot report for February 2021 reflecting reported revenue for all tracked categories, including Trade (Consumer Books), K-12 Instructional Materials, Higher Education Course Materials, Professional Publishing, and University Presses. Total revenues across all categories for February 2021 were up 24.7% as compared to February 2020, coming in at $964.5 million. Year to date revenues were up 16.4%, at $2.2 billion for the first two months of the year. click read more below for details
With only the adult and YA fiction categories posting increases, unit sales of print books still rose 4.1% in the week ended June 5, 2021, over the comparable week in 2020, at outlets that report to NPD BookScan. Seven of the top 10 bestsellers in the week were new fiction releases, including three graphic novels from Viz Media that sold a combined 68,000 copies. The top three sellers in the week were Golden Girl by Elin Hilderbrand (more than 50,000 copies), Freed: Fifty Shades Freed as Told by Christian by E.L. James (more than 48,000 copies), and Casey McQuiston’s One Last Stop (more than 31,000 copies). Unit sales increased 19.7% in YA fiction without the benefit of a new bestseller. Adam Silvera’s They Both Die in the End remained #1 in the category, selling just over 15,000 copies.
Hearst announced it has agreed to acquire CellTrak, a leading provider of care documentation software solutions in the personal care market. The announcement was made by Steven R. Swartz, Hearst president and CEO; Gregory Dorn, MD, Hearst Health president; Scott Decker, Homecare Homebase president; and Dan Wacker, CellTrak CEO. Terms were not disclosed and the transaction is expected to close in Q1 of 2022. CellTrak will become a wholly owned subsidiary of Homecare Homebase, with Wacker continuing as general manager of the company. “In-home care services have grown significantly the past 10 years as it is the preferred venue for people to receive care, and Homecare Homebase has been the leading platform providing vital workflow solutions in the home health and hospice categories,” said Dorn. “Extending their capabilities to personal care is the right next step for caregiving in the home.”